Does ROSUVASTATIN Cause Coronary artery occlusion? 283 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 283 reports of Coronary artery occlusion have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.8% of all adverse event reports for ROSUVASTATIN.
283
Reports of Coronary artery occlusion with ROSUVASTATIN
0.8%
of all ROSUVASTATIN reports
2
Deaths
176
Hospitalizations
How Dangerous Is Coronary artery occlusion From ROSUVASTATIN?
Of the 283 reports, 2 (0.7%) resulted in death, 176 (62.2%) required hospitalization, and 7 (2.5%) were considered life-threatening.
Is Coronary artery occlusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 283 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Coronary artery occlusion?
ADALIMUMAB (1,392)
TICAGRELOR (370)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (296)
METOPROLOL (230)
SACUBITRIL\VALSARTAN (204)
ASPIRIN (190)
RISANKIZUMAB-RZAA (181)
EVOLOCUMAB (162)
CLOPIDOGREL BISULFATE (155)
ATORVASTATIN (149)
Which ROSUVASTATIN Alternatives Have Lower Coronary artery occlusion Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN